E

EstechPharma Co Ltd
KOSDAQ:041910

Watchlist Manager
EstechPharma Co Ltd
KOSDAQ:041910
Watchlist
Price: 7 000 KRW -0.14%
Market Cap: ₩94.5B

Net Margin

12.3%
Current
Improving
by 10.5%
vs 3-y average of 1.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.3%
=
Net Income
₩7.1B
/
Revenue
₩57.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.3%
=
Net Income
₩7.1B
/
Revenue
₩57.5B

Peer Comparison

Country Company Market Cap Net
Margin
KR
EstechPharma Co Ltd
KOSDAQ:041910
93.1B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

Higher than 85% of companies in Korea
Percentile
85th
Based on 2 632 companies
85th percentile
12.3%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

EstechPharma Co Ltd
Glance View

Market Cap
94.5B KRW
Industry
Pharmaceuticals

Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 162 full-time employees. The company went IPO on 2004-02-06. The Company’s products include remedies for alcoholism, anti-inflammatory, muscle relaxant, anti-septic, anti-spasmodic, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, anti-histamine, anti-ulcerants, anti-rheumatics, anti-anemia, anti-diabetic, insecticide, anti-hypertensive, anti-asthmatic and anti-depressants, among others. The company has a research and development institute, which develops APIs. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
7 544.36 KRW
Undervaluation 7%
Intrinsic Value
Price
E
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12.3%
=
Net Income
₩7.1B
/
Revenue
₩57.5B
What is EstechPharma Co Ltd's current Net Margin?

The current Net Margin for EstechPharma Co Ltd is 12.3%, which is above its 3-year median of 1.8%.

How has Net Margin changed over time?

Over the last 3 years, EstechPharma Co Ltd’s Net Margin has increased from 1.5% to 12.3%. During this period, it reached a low of -10.3% on Dec 31, 2022 and a high of 12.3% on Sep 30, 2025.

Back to Top